Lyell Immunopharma Inc

XNAS:LYEL 4:00:00 PM EDT

21.25

-3.52 (-14.23%)

4:23:08 PM EDT: $21.55 +0.30 (+1.41%)

Market Cap (Intraday)	451.42M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.02 Million
Adjusted EPS	-$2.23

See more estimates

10-Day MA	$23.72
50-Day MA	$24.34
200-Day MA	$17.82

See more pivots

Lyell Immunopharma Inc Stock, XNAS:LYEL

201 Haskins Way, Suite 101, South San Francisco, California 94080

United States of America

Phone: +1.650.695.0677

Number of Employees: 300

http://www.lyell.com

Description

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.